Skip to content

Acquisitions at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$8.87B
Repligen logo
RepligenRGEN
$0-100%
Agilent Technologies logo
Agilent TechnologiesA
$0
Charles River Laboratories logo
Charles River LaboratoriesCRL
$405.01M
Azenta logo
AzentaAZTA
$0
Illumina logo
IlluminaILMN
$415M+5,829%

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s acquisitions?
Maravai LifeSciences Holdings, Inc. (MRVI) reported acquisitions of $0 in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s acquisitions changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s acquisitions decreased by 100.0% year-over-year, from $18.63M to $0.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.